Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.96ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.96ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.96ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.96NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.8.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.8.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CM.8.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
CM.8.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used